Best Kinase Inhibitor for carcinoma, renal cell
6 Kinase Inhibitor drugs used for carcinoma, renal cell, ranked by our independent rating. Compare them with all treatments for carcinoma, renal cell or the full Kinase Inhibitor class. Not medical advice — always consult a professional.
Quick answer: Of the 6 kinase inhibitor drugs we rate for carcinoma, renal cell, none are yet flagged as generics in our price data, and most are tablet. Our ranking reflects each drug’s FDA recall-safety record — not clinical effectiveness for carcinoma, renal cell; the right choice depends on your situation, so confirm it with your prescriber.
How kinase inhibitor work
Kinase inhibitors block protein kinases, the enzymes that relay 'grow and divide' signals inside cells. By shutting down the overactive kinase signals that a tumor depends on, they help slow or stop cancer cells from multiplying.
Source: Tyrosine Kinase Inhibitors - StatPearls - NCBI Bookshelf
Other drug classes for carcinoma, renal cell
Top kinase inhibitor for carcinoma, renal cell: 1. Cabometyx · 2. Cometriq · 3. Inlyta
| # | Drug | Rating | Type | Form | Generic? | Pharmacy pays | |
|---|---|---|---|---|---|---|---|
| 1 | Not yet rated | Prescription | Tablet | No data | — | View → | |
| 2 | Not yet rated | Prescription | Capsule | No data | — | View → | |
| 3 | Not yet rated | Prescription | Tablet | No data | — | View → | |
| 4 | Not yet rated | Prescription | Tablet | No data | — | View → | |
| 5 | Not yet rated | Prescription | Tablet | No data | — | View → | |
| 6 | Not yet rated | Prescription | Capsule | No data | — | View → |
Full ranking · 6 drugs
cabometyx
PrescriptionFDA-sourced
Cabometyx (Cabozantinib S-Malate) is a kinase inhibitor used to treat Renal Cell Carcinoma.
Price varies
cometriq
PrescriptionFDA-sourced
Cometriq (Cabozantinib S-Malate) is a kinase inhibitor used to treat Renal Cell Carcinoma.
Price varies
inlyta
PrescriptionFDA-sourced
Inlyta (Axitinib) is a kinase inhibitor used to treat Renal Cell Carcinoma.
Price varies
nexavar
PrescriptionFDA-sourced
Nexavar (Sorafenib Tosylate) is a kinase inhibitor used to treat Renal Cell Carcinoma, Hepatocellular Carcinoma, Thyroid Neoplasms.
Price varies
sorafenib tosylate
PrescriptionFDA-sourced
Sorafenib Tosylate is a kinase inhibitor used to treat Renal Cell Carcinoma, Hepatocellular Carcinoma, Thyroid Neoplasms.
Price varies
sutent
Boxed warningPrescriptionFDA-sourced
Sutent (Sunitinib Malate) is a kinase inhibitor used to treat Renal Cell Carcinoma, Pancreatic Neoplasms, Neuroendocrine Tumors, Gastrointestinal Stromal Tumors.
Price varies
Frequently asked
- What is the best kinase inhibitor for carcinoma, renal cell?
- Ratings are based on FDA regulatory recall-safety data — always consult a professional.
- Which kinase inhibitor drugs treat carcinoma, renal cell?
- pharmaranks lists 6 Kinase Inhibitor products used for carcinoma, renal cell, per NIH RxClass drug-classification data — each independently rated and ranked above.
- How are these ranked?
- By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.